Kevin Sublett is a Cardiology physician. OpenAlex indexes 8 publications with 559 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3368 Highway 280
Suite 130
Alexander City, AL 350103393
Telephone
256-234-2644Registry record last updated 29 Sept 2014.
Industry payments
35 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20252 payments
- Actelion Pharmaceuticals US, Inc.Program year20259 payments
- Novo Nordisk IncProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
79.5%Beta blocker15.7%Metoprolol Succinate57%Sotalol19%Carvedilol14%Metoprolol Tartrate5%Atenolol3%Nebivolol Hcl2%Part D<11 patientsStatin14.8%Atorvastatin Calcium82%Rosuvastatin Calcium18%Part D≥306 patients+ 20 more classes in this area
Blood & clotting
15%Factor Xa inhibitor7.9%Eliquis84%Xarelto16%Part D≥104 patientsP2Y12 inhibitor5.8%Clopidogrel96%Prasugrel Hcl4%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
4.4%SGLT2 inhibitor2.1%Farxiga69%Jardiance31%Part D≥33 patientsGLP-1 receptor agonist1.2%Ozempic56%Mounjaro44%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Is routine automated quantitative analysis of coronary arteriography feasible? Evaluation of operator-dependent variables inherent to the technique
Journal of the American College of Cardiology
1990 - Resolution of spontaneous contrast with platelet disaggregatory therapy (trifluoperazine)
The American Journal of Cardiology
1989
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”